[go: up one dir, main page]

WO2001032692A3 - Peptide mimics of conserved gonococcal epitopes and methods and compositions using them - Google Patents

Peptide mimics of conserved gonococcal epitopes and methods and compositions using them Download PDF

Info

Publication number
WO2001032692A3
WO2001032692A3 PCT/US2000/029749 US0029749W WO0132692A3 WO 2001032692 A3 WO2001032692 A3 WO 2001032692A3 US 0029749 W US0029749 W US 0029749W WO 0132692 A3 WO0132692 A3 WO 0132692A3
Authority
WO
WIPO (PCT)
Prior art keywords
compositions
methods
peptide mimics
epitopes
conserved
Prior art date
Application number
PCT/US2000/029749
Other languages
French (fr)
Other versions
WO2001032692A2 (en
Inventor
Peter A Rice
Jutamas Ngampasutadol
Sunita Gulati
Original Assignee
Peter A Rice
Jutamas Ngampasutadol
Sunita Gulati
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peter A Rice, Jutamas Ngampasutadol, Sunita Gulati filed Critical Peter A Rice
Priority to AU12420/01A priority Critical patent/AU785022B2/en
Priority to NZ518915A priority patent/NZ518915A/en
Priority to CN008170983A priority patent/CN1409725B/en
Priority to APAP/P/2002/002511A priority patent/AP1638A/en
Publication of WO2001032692A2 publication Critical patent/WO2001032692A2/en
Publication of WO2001032692A3 publication Critical patent/WO2001032692A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention relates to peptide mimics of a conserved gonoccocal epitode of Neisseria gonorrhoeae, which epitope is not found on human blood group antigens. This invention also relates to methods and compositions using such peptide mimics for the prophylaxis of gonorrheal infections.
PCT/US2000/029749 1999-10-29 2000-10-27 Peptide mimics of conserved gonococcal epitopes and methods and compositions using them WO2001032692A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU12420/01A AU785022B2 (en) 1999-10-29 2000-10-27 Peptide mimics of conserved gonococcal epitopes and methods and compositions using them
NZ518915A NZ518915A (en) 1999-10-29 2000-10-27 Peptide mimics of conserved gonococcal epitopes and methods and compositions using them for immunizing against Neisseria gonorrhoeae
CN008170983A CN1409725B (en) 1999-10-29 2000-10-27 Peptoids of conserved gonococcal epitopes and methods and compositions employing them
APAP/P/2002/002511A AP1638A (en) 1999-10-29 2000-10-27 Peptide mimics of conserved gonococcal epitopes and methods and compositions using them.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16249199P 1999-10-29 1999-10-29
US60/162,491 1999-10-29

Publications (2)

Publication Number Publication Date
WO2001032692A2 WO2001032692A2 (en) 2001-05-10
WO2001032692A3 true WO2001032692A3 (en) 2002-03-07

Family

ID=22585848

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/029749 WO2001032692A2 (en) 1999-10-29 2000-10-27 Peptide mimics of conserved gonococcal epitopes and methods and compositions using them

Country Status (7)

Country Link
CN (2) CN101638433B (en)
AP (1) AP1638A (en)
AU (1) AU785022B2 (en)
HK (1) HK1141034A1 (en)
NZ (2) NZ532271A (en)
OA (1) OA12315A (en)
WO (1) WO2001032692A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101899097B (en) * 2010-07-07 2012-02-01 南方医科大学 A kind of B blood group antigen epitope mimetic peptide and its application
CN101899096B (en) * 2010-07-07 2012-07-04 南方医科大学 Blood group A epitope mimic peptide and application thereof
EP4034155A4 (en) * 2019-09-23 2024-01-10 University of Massachusetts MULTIANTIGEN PEPTIDE MIMETICS OF GONOCOCCIAL LIPO-OLIGOSACCHARIDE (LOS) EPITOPES

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994022479A1 (en) * 1993-04-06 1994-10-13 Trustees Of Health & Hospitals Of The City Of Boston Gonococcal anti-idiotypic antibodies and methods and compositions using them
WO1997046582A1 (en) * 1996-06-05 1997-12-11 Peptide Therapeutics Limited Meningococcal vaccine
WO1999011660A2 (en) * 1997-09-04 1999-03-11 Institut Pasteur Immunogenic polypeptides that mimic a surface polysaccharide antigen of a pathogenic microorganism, method for obtaining the same, and their use in vaccine compositions
WO1999040189A2 (en) * 1998-02-09 1999-08-12 Genset Cdnas encoding secreted proteins

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994022479A1 (en) * 1993-04-06 1994-10-13 Trustees Of Health & Hospitals Of The City Of Boston Gonococcal anti-idiotypic antibodies and methods and compositions using them
WO1997046582A1 (en) * 1996-06-05 1997-12-11 Peptide Therapeutics Limited Meningococcal vaccine
WO1999011660A2 (en) * 1997-09-04 1999-03-11 Institut Pasteur Immunogenic polypeptides that mimic a surface polysaccharide antigen of a pathogenic microorganism, method for obtaining the same, and their use in vaccine compositions
WO1999040189A2 (en) * 1998-02-09 1999-08-12 Genset Cdnas encoding secreted proteins

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DEMPSEY PW ET AL: "C3d OF COMPLEMENT AS A MOLECULAR ADJUVANT: BRIDGING INATE AND ACQUIRED IMMUNITY", SCIENCE,US,AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, vol. 271, 19 January 1996 (1996-01-19), pages 348 - 350, XP002095252, ISSN: 0036-8075 *
KIEBER-EMMONS T: "PEPTIDE MIMOTOPES OF CARBOHYDRATE ANTIGENS", IMMUNOLOGIC RESEARCH,CH,KARGER, BASEL, vol. 17, no. 1-02, January 1998 (1998-01-01), pages 95 - 108, XP000892784, ISSN: 0257-277X *

Also Published As

Publication number Publication date
CN101638433A (en) 2010-02-03
HK1141034A1 (en) 2010-10-29
CN1409725A (en) 2003-04-09
WO2001032692A2 (en) 2001-05-10
OA12315A (en) 2006-05-15
AU785022B2 (en) 2006-08-24
AP1638A (en) 2006-07-20
AP2002002511A0 (en) 2002-06-30
NZ532271A (en) 2006-03-31
CN1409725B (en) 2012-06-06
NZ518915A (en) 2004-05-28
AU1242001A (en) 2001-05-14
CN101638433B (en) 2014-10-29

Similar Documents

Publication Publication Date Title
WO2000018351A3 (en) Aglyco products and methods of use
WO2000053758A3 (en) Compositions and methods for the treatment of immune related diseases
AU2002302255A1 (en) Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
WO2006021955A3 (en) Use of bat monoclonal antibody for immunotherapy
WO2001039796A3 (en) Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
WO2000076540A3 (en) Streptococcus pneumoniae proteins and vaccines
WO2005018424A3 (en) Antibodies specific for fibrillar amyloid and a procedure to detect fibrillar amyloid deposits
CA2025597A1 (en) Vaccine against lyme disease
WO2000073452A3 (en) Compositions and methods for the treatment of immune related diseases
EP2213684A3 (en) Nogo-a antibodies for the treatment of Alzheimer disease
SG48816A1 (en) Gonococcal anti-idiotypic antibodies and methods and compositions using them
EP1818062A3 (en) An anti HSP90 antibody
HK1072264A1 (en) Synthetic peptide vaccines for hiv: the cbd epitope as an effective immunogen to elicit broadly neutralizing antibodies against hiv
WO2003015702A3 (en) Epitopes of human immunodeficiency virus-1
WO2003059260A3 (en) Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
WO2004081199A3 (en) Novel compositions and methods for the treatment of immune related disease
WO2001040473A3 (en) Pseudomonas aeruginosa antigens
WO2001032692A3 (en) Peptide mimics of conserved gonococcal epitopes and methods and compositions using them
AU1041397A (en) Antigenic protein originating in malassezia
HK1063057A1 (en) Pharmaceutical composition of f(ab) 2 fragments of antibodies and method for the preparation thereof
NO972522L (en) Monoclonal antibodies with immunosuppressive activity
WO2003055440A8 (en) Compositions and methods for the treatement of immune related diseases
WO2002041921A3 (en) Compositions for protection against bovine viral diseases
WO2000015797A3 (en) Compositions and methods for the treatment of immune related diseases
WO2004043397A3 (en) Compositions and methods for the treatment of rheumatoid arthritis

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 12420/01

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 518915

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 008170983

Country of ref document: CN

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
WWP Wipo information: published in national office

Ref document number: 518915

Country of ref document: NZ

NENP Non-entry into the national phase

Ref country code: JP

WWG Wipo information: grant in national office

Ref document number: 518915

Country of ref document: NZ